BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37284216)

  • 1. Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters.
    Khattab A; Charlton RW
    Front Endocrinol (Lausanne); 2023; 14():1127558. PubMed ID: 37284216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies.
    Sarafoglou K; Barnes CN; Huang M; Imel EA; Madu IJ; Merke DP; Moriarty D; Nakhle S; Newfield RS; Vogiatzi MG; Auchus RJ
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4666-e4679. PubMed ID: 34146101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of fertility by gonadotropin replacement in a man with hypogonadotropic azoospermia and testicular adrenal rest tumors due to untreated simple virilizing congenital adrenal hyperplasia.
    Rohayem J; Tüttelmann F; Mallidis C; Nieschlag E; Kliesch S; Zitzmann M
    Eur J Endocrinol; 2014 Apr; 170(4):K11-7. PubMed ID: 24394723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular adrenal rest tumours in young adult males with congenital adrenal hyperplasia: prevalence and impact on testicular function.
    Chihaoui M; Kanoun F; Chaker F; Yazidi M; Bouchrit K; Mizouni H; Feki M; Kharrat M; Slimane H
    Andrologia; 2016 Feb; 48(1):45-50. PubMed ID: 25880899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testicular adrenal rest tumor screening and fertility counseling among males with congenital adrenal hyperplasia.
    Chaudhari M; Johnson EK; DaJusta D; Nahata L
    J Pediatr Urol; 2018 Apr; 14(2):155.e1-155.e6. PubMed ID: 29330018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients.
    Claahsen-van der Grinten HL; Otten BJ; Takahashi S; Meuleman EJ; Hulsbergen-van de Kaa C; Sweep FC; Hermus AR
    J Clin Endocrinol Metab; 2007 Feb; 92(2):612-5. PubMed ID: 17090637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
    King TF; Lee MC; Williamson EE; Conway GS
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):830-6. PubMed ID: 26666213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
    Auchus RJ; Sarafoglou K; Fechner PY; Vogiatzi MG; Imel EA; Davis SM; Giri N; Sturgeon J; Roberts E; Chan JL; Farber RH
    J Clin Endocrinol Metab; 2022 Feb; 107(3):801-812. PubMed ID: 34653252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OHD) in adult males: Clinical presentation, hormone function and the detection of adrenal and testicular adrenal rest tumors (TARTs).
    San Martín P; Eugenio Russmann ML; Mendeluk G; Fierro MF; Marino R; Pardes E
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Apr; 68(4):227-235. PubMed ID: 34266634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal function in adult male patients with congenital adrenal hyperplasia.
    Engels M; Gehrmann K; Falhammar H; Webb EA; Nordenström A; Sweep FC; Span PN; van Herwaarden AE; Rohayem J; Richter-Unruh A; Bouvattier C; Köhler B; Kortmann BB; Arlt W; Roeleveld N; Reisch N; Stikkelbroeck NMML; Claahsen-van der Grinten HL;
    Eur J Endocrinol; 2018 Mar; 178(3):285-294. PubMed ID: 29339528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for testicular adrenal rest tumors in pediatric patients with congenital adrenal hyperplasia.
    Rivera-Hernandez A; Jimenez-Osorio M; Rodríguez-Mencias JP; Escamilla-Castañeda KM; Madrigal-Gonzalez MM; Zurita-Cruz J
    J Pediatr Urol; 2023 Aug; 19(4):398.e1-398.e7. PubMed ID: 37029011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia.
    Stikkelbroeck NM; Otten BJ; Pasic A; Jager GJ; Sweep CG; Noordam K; Hermus AR
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5721-8. PubMed ID: 11739428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for testicular adrenal rest tumors among children with congenital adrenal hyperplasia at King Fahad Medical City, Saudi Arabia.
    Huneif MA; Al Mutairi M; AlHazmy ZH; AlOsaimi FK; AlShoomi AM; AlGhofely MA; AlSaheel A
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):49-54. PubMed ID: 34757702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue.
    Claahsen-van der Grinten HL; Otten BJ; Sweep FC; Span PN; Ross HA; Meuleman EJ; Hermus AR
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3674-80. PubMed ID: 17595257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular adrenal rest tumors in children with congenital adrenal hyperplasia.
    Al-Ghamdi WM; Shazly MA; Al-Agha AE
    Saudi Med J; 2021 Sep; 42(9):986-993. PubMed ID: 34470837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion.
    Hayes FJ; DeCruz S; Seminara SB; Boepple PA; Crowley WF
    J Clin Endocrinol Metab; 2001 Jan; 86(1):53-8. PubMed ID: 11231978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.